EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN

EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN

Show other versions (1)

The article presents results of a study of tolerability of recombinant human granulocyte colony-stimulating factor (G-CSF) Leukostim and its efficacy compared to Neupogen in patients with neutropenia, associated with chemotherapy of malignant tumors in children. At the 1st stage (randomized double-b...

Full description

Bibliographic Details
Main Authors:	A.A. Maschan, L.G. Fechina, O.P. Khlebnikova, N.Yu. Shipovskaya, E.V. Samochatova, O.B. Polushkina
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2010-01-01
Series:	Вопросы современной педиатрии
Online Access:	https://vsp.spr-journal.ru/jour/article/view/823

Similar Items

EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN
by: A.A. Maschan, et al.
Published: (2010-01-01)

Immediate side effects study of locally manufactured filgrastim («Leucostim®») in neutropenia treatment and prophylactics in children
by: N. Yu. Shipovskaya, et al.
Published: (2022-11-01)

A case of chronic granulocytopenia associated with vasculitis and amyloidosis
by: Jennings, G, et al.
Published: (1973)

Bioanalogues oj juvenile hormones and intestines mycoflora of some insects
by: Andrzej Nespiak, et al.
Published: (2014-08-01)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
by: Innocenti R, et al.
Published: (2018-12-01)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum]
by: Innocenti R, et al.
Published: (2019-02-01)

Risk Factors for Granulocytopenia in Patients with Graves’ Disease Receiving Antithyroid Drugs
by: Jiaxi Li, et al.
Published: (2023-01-01)

EFFECTIVENESS AND SAFETY OF RECOMBINANT HUMAN GRANULOCYTIC COLONY-STIMULATING FACTOR IN TREATMENT OF GRANULOCYTOPENIA DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2010-01-01)

EFFECTIVENESS AND SAFETY OF RECOMBINANT HUMAN GRANULOCYTIC COLONY-STIMULATING FACTOR IN TREATMENT OF GRANULOCYTOPENIA DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2010-07-01)

Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
by: Otremba B, et al.
Published: (2018-10-01)

Innovator Filgrastim versus Generic Filgrastim in Hematopoietic Stem Cell Transplantation Mobilization
by: Sadik Husian, et al.
Published: (2021-09-01)

Biosimilars in the management of neutropenia: focus on filgrastim
by: Caselli D, et al.
Published: (2016-02-01)

A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
by: Roberto Hegg, et al.

Development and certification of an industrial reference standard for determination of filgrastim activity
by: E. V. Motuzova, et al.
Published: (2018-02-01)

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
by: Schwartzberg LS, et al.
Published: (2018-09-01)

The Comparison of The Efficacy and Safety of Original and Biosimilar Filgrastim in Prevention of Chemotherapy-Induced Neutropenia in Children with Cancer
by: Mustafa Buyukavci, et al.
Published: (2019-06-01)

Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
by: Choi C, et al.
Published: (2018-08-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
by: Adam F. Binder, et al.
Published: (2017-10-01)

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
by: Naeim Arash, et al.
Published: (2013-01-01)

Effects of Ocimum tenuiflorum on Induced Testicular Degeneration by Filgrastim in Wistar Rats
by: G. S Tuimah Alabedi, et al.
Published: (2021-11-01)

Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients
by: Siw Johannesen, et al.
Published: (2018-11-01)

A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects
by: Adar L, et al.
Published: (2015-05-01)

SUCCESSFUL REGISTRATION OF DOMESTIC BIOANALOGUE OF BEVACIZUMAB – NEW OPPORTUNITIES FOR EFFECTIVE TREA TMENT OF PATIENTS WITH NON-SQUAMOUS CELL NON-SMALL CELL LUNG CANCER
by: S. V. Orlov, et al.
Published: (2016-01-01)

Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis
by: Shruti Rastogi, et al.
Published: (2021-10-01)

Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
by: Alexander Y. Mayorov, et al.
Published: (2018-12-01)

Characterization and comparability of biosimilars: A filgrastim case of study and regulatory perspectives for Latin America
by: Karina Mendoza-Macedo, et al.
Published: (2016-11-01)

Comparative Analysis of Dyes Used in the Assessment of Filgrastim Products Specific Activity by Biological <i>in vitro</i> Methods
by: O. V. Golovinskaya, et al.
Published: (2020-09-01)

ANALYSIS AND RELEVANCE OF DATA ABOUT ADDITIONAL STABILITY OF NIVESTIM™ ( FILGRASTIM SOLUTION FOR INJECTION )
by: António Melo Gouveia
Published: (2012-06-01)

Filgrastim Induced Severe Leukocytosis in Sepsis-Associated Leukopenia: A Case Repor
by: Foroud Shahbazi, et al.
Published: (2019-07-01)

Filgrastim-related acute kidney injury in a male renal transplant recipient
by: Priya Haridas Anupama, et al.
Published: (2018-01-01)

Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome
by: John Harrold, et al.
Published: (2020-07-01)

Analysis of ANC Levels after Filgrastim Therapy in Acute Leukemia Children with Neutropenia
by: Reta Anggraeni Widya, et al.
Published: (2021-01-01)

ROLE OF GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF)/ FILGRASTIM AS AN ADJUNCT IN CHRONIC HEPATITIS C MANAGEMENT
by: Fazal A Danish
Published: (2009-07-01)

Family platelet disorder with propensity to acute myeloid leukemia: new family with RUNX1 mutation
by: V. O. Bobrynina, et al.
Published: (2014-07-01)

Family platelet disorder with propensity to acute myeloid leukemia: new family with RUNX1 mutation
by: V. O. Bobrynina, et al.
Published: (2014-07-01)

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database
by: Shruti Rastogi, et al.
Published: (2022-02-01)

ROLE OF GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF)/FILGRASTIM AS AN ADJUNCT IN CHRONIC HEPATITIS C MANAGEMENT
by: Fazal A. Danish, et al.
Published: (2009-06-01)

ROLE OF GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF)/FILGRASTIM AS AN ADJUNCT IN CHRONIC HEPATITIS C MANAGEMENT
by: Fazal A. Danish, et al.
Published: (2009-06-01)

Rescate medular con filgrastim y ácido folínico en intoxicación por metotrexato
by: Marlon Villacís Aveiga, et al.
Published: (2019-04-01)

Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction—The REC-DUT-002 Trial
by: Dirk von Lewinski, et al.
Published: (2022-09-01)